Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
Condition(s):Hemophagocytic LymphohistiocytosesLast Updated:September 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hemophagocytic LymphohistiocytosesLast Updated:September 21, 2023Completed
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:July 20, 2018Terminated
Condition(s):Haemophagocytic LymphohistiocytosisLast Updated:January 9, 2024Not yet recruiting
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:March 12, 2024Recruiting
Condition(s):Hemophagocytic LymphohistiocytosesLast Updated:December 7, 2023Not yet recruiting
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:September 10, 2020Unknown status
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:October 29, 2019Unknown status
Condition(s):Hemophagocytic LymphohistiocytosesLast Updated:January 16, 2024Recruiting
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:September 6, 2019Unknown status
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:January 4, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.